Cargando…

Soluble Epoxide Hydrolase Inhibition Prevents Experimental Type 4 Cardiorenal Syndrome

Objectives: Cardiovascular diseases (CVD) remain the leading cause of morbimortality in patients with chronic kidney disease (CKD). The aim of this study was to assess the cardiovascular impact of the pharmacological inhibition of soluble epoxide hydrolase (sEH), which metabolizes the endothelium-de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamzaoui, Mouad, Roche, Clothilde, Coquerel, David, Duflot, Thomas, Brunel, Valery, Mulder, Paul, Richard, Vincent, Bellien, Jérémy, Guerrot, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991096/ https://www.ncbi.nlm.nih.gov/pubmed/33777999 http://dx.doi.org/10.3389/fmolb.2020.604042

Ejemplares similares

5/6 nephrectomy induces different renal, cardiac and vascular consequences in 129/Sv and C57BL/6JRj mice
por: Hamzaoui, Mouad, et al.
Publicado: (2020)

Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats
por: Leuillier, Matthieu, et al.
Publicado: (2023)

Preservation of epoxyeicosatrienoic acid bioavailability prevents renal allograft dysfunction and cardiovascular alterations in kidney transplant recipients
por: Duflot, Thomas, et al.
Publicado: (2021)

The Metabolism of Epoxyeicosatrienoic Acids by Soluble Epoxide Hydrolase Is Protective against the Development of Vascular Calcification
por: Varennes, Olivier, et al.
Publicado: (2020)

Soluble Epoxide Hydrolase in Atherosclerosis
por: Wang, Yi-Xin Jim, et al.
Publicado: (2010)

Soluble Epoxide Hydrolase and Diabetes Complications
por: Anita, Natasha Z., et al.
Publicado: (2022)

CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury
por: Leuillier, Matthieu, et al.
Publicado: (2022)

Inhibition of Soluble Epoxide Hydrolase for Renal Health
por: Liu, Jun-Yan
Publicado: (2019)

Soluble Epoxide Hydrolase and Brain Cholesterol Metabolism
por: Domingues, Michelle Flores, et al.
Publicado: (2020)

Evaluation of fish models of soluble epoxide hydrolase inhibition.
por: Newman, J W, et al.
Publicado: (2001)

Disrupting Dimerization Translocates Soluble Epoxide Hydrolase to Peroxisomes
por: Nelson, Jonathan W., et al.
Publicado: (2016)

Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
por: Imig, John D., et al.
Publicado: (2020)

The role of soluble epoxide hydrolase and its inhibitors in depression
por: Borsini, Alessandra
Publicado: (2021)

Discovery of Kasugamycin as a Potent Inhibitor of Glycoside Hydrolase Family 18 Chitinases
por: Qi, Huitang, et al.
Publicado: (2021)

A New Subfamily of Glycoside Hydrolase Family 30 with Strict Xylobiohydrolase Function
por: Crooks, Casey, et al.
Publicado: (2021)

Functional Diversity of Mitochondrial Peptidyl-tRNA Hydrolase ICT1 in Human Cells
por: Chicherin, I.V., et al.
Publicado: (2021)

Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors
por: Kodani, Sean D., et al.
Publicado: (2018)

Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation
por: Brenneis, Christian, et al.
Publicado: (2011)

Effects of Soluble Epoxide Hydrolase Deficiency on Acute Pancreatitis in Mice
por: Bettaieb, Ahmed, et al.
Publicado: (2014)

Inhibition of soluble epoxide hydrolase increases coronary perfusion in mice
por: Qin, Jun, et al.
Publicado: (2015)

Dysregulation of Soluble Epoxide Hydrolase and Lipidomic Profiles in Anorexia Nervosa
por: Shih, Pei-an Betty, et al.
Publicado: (2015)

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent Vasodilators
por: Tripathi, Neetika, et al.
Publicado: (2018)

Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future
por: Park, Bomina, et al.
Publicado: (2019)

Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
por: McReynolds, Cindy B., et al.
Publicado: (2019)

Soluble Epoxide Hydrolase as a Therapeutic Target for Neuropsychiatric Disorders
por: Shan, Jiajing, et al.
Publicado: (2022)

Inhibitory Activity of Quaternary Isoquinoline Alkaloids on Soluble Epoxide Hydrolase
por: Kim, Jang Hoon, et al.
Publicado: (2022)

Inhibition of Soluble Epoxide Hydrolase Activity by Components of Glycyrrhiza uralensis
por: Kim, Jang Hoon, et al.
Publicado: (2023)

Soluble epoxide hydrolase inhibitor promotes the healing of oral ulcers
por: Li, Juanjuan, et al.
Publicado: (2023)

Biochemical and Structural Characterization of Thermostable GH159 Glycoside Hydrolases Exhibiting α-L-Arabinofuranosidase Activity
por: Baudrexl, Melanie, et al.
Publicado: (2022)

Genetic Deletion of Soluble Epoxide Hydrolase Attenuates Inflammation and Fibrosis in Experimental Obstructive Nephropathy
por: Chiang, Chin-Wei, et al.
Publicado: (2015)

Role of Endothelial Soluble Epoxide Hydrolase in Cerebrovascular Function and Ischemic Injury
por: Zhang, Wenri, et al.
Publicado: (2013)

Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice
por: Zhu, Ye, et al.
Publicado: (2016)

Exploring the origins of selectivity in soluble epoxide hydrolase from Bacillus megaterium
por: Serrano-Hervás, Eila, et al.
Publicado: (2017)

Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders
por: Hashimoto, Kenji
Publicado: (2019)

Vascular repair and anti-inflammatory effects of soluble epoxide hydrolase inhibitor
por: Dai, Na, et al.
Publicado: (2019)

Selection of Potent Inhibitors of Soluble Epoxide Hydrolase for Usage in Veterinary Medicine
por: Shihadih, Diyala S., et al.
Publicado: (2020)

Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer’s disease
por: Lee, Hsueh-Te, et al.
Publicado: (2019)

Age and Sex Differences in Hearts of Soluble Epoxide Hydrolase Null Mice
por: Jamieson, K. Lockhart, et al.
Publicado: (2020)

Redox Regulation of Soluble Epoxide Hydrolase—Implications for Cardiovascular Health and Disease
por: Charles, Rebecca, et al.
Publicado: (2022)

Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization
por: Park, Bomina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3oulfda0sq3dce07u9bdf6lq08